Royalty Pharma plc

Royalty Pharma buys the rights to receive payments from sales of pharmaceutical drugs. When a drug company sells a medicine, Royalty Pharma receives a percentage of those sales as royalty payments. The company owns royalty rights to about 35 drugs already on the market and has stakes in about 20 experimental drugs in development, covering treatments for rare diseases, cancer, neurological conditions, infections, blood disorders, and diabetes. The company also funds research to help develop new medicines.